Sign in to view content

Ranibizumab Induces Regression of Diabetic Retinopathy

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2016

Related

Expert Panel: Faricimab and Aflibercept 8 mg in AMD
John T. Thompson, MD
Andrew A. Moshfeghi, MD, MBA, FASRS
Manjot K Gill, MD, FASRS
Christina Y Weng, MD, MBA, FASRS
Ferhina S Ali, MD, MPH
Ian Pearce, MB ChB BSc FRCOPHTH
Annual Meeting Talks
2024
Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial
Philip J. Ferrone, MD, FASRS
Annual Meeting Talks
2019
Outcomes of Treatment-naïve Eyes With Proliferative Diabetic Retinopathy Treated With Navigated Laser (NAVILAS) Pan-retinal Photocoagulation
Pradeep Satya Prasad, MD, MBA
On Demand Cases, Courses, and Papers
2020

Category: Diabetic Retinopathy

See more